Mice with diabetes successfully treated with EMFs

Dovie Salais

Researchers have worked out how to use electromagnetic fields to treat mice with type 2 diabetes.

Scientists have discovered that they can successfully treat type 2 diabetes in mouse models by exposing the rodents to electromagnetic fields.

The research, which appears in the journal Cell Metabolism, opens the door to further studies confirming the findings and exploring whether the therapy could be suitable for use in humans.

According to the Centers for Disease Control and Prevention (CDC), more than 34 million people — approximately 1 in 10 — in the United States have diabetes. Of these individuals, the vast majority have type 2 diabetes.

Type 2 diabetes occurs when a person’s cells do not react to the hormone insulin properly. Insulin, which the pancreas produces, mediates the ability of a person’s cells to receive blood sugar.

In this situation, a person’s body can tell that their cells are not

Read More

Cow dung chip reduces radiation from mobiles, safeguard against diseases: Rashtriya Kamdhenu Aayog chief

Dovie Salais

New Delhi [India], October 13 (ANI): Rashtriya Kamdhenu Aayog (RKA) chairman Vallabhbhai Kathiria unveiled a ‘chip’ made of cow dung and claimed that it reduces radiation from mobile handsets and it will be a safeguard against diseases.

Speaking at the launch of a nationwide campaign ‘Kamdhenu Deepawali Abhiyan’, which is aimed at promoting cow dung products, Kathiria said: “Cow dung will protect everyone, it is anti-radiation… It is scientifically proven…This is a radiation chip that can be used in mobile phones to reduce radiation. It will be safeguarded against diseases.”
The ‘chip’, named Gausatva Kavach, is manufactured by Rajkot-based Shrijee Gaushala.

Set up in 2019, the RKA aimed at conservation, protection and development of cows and their progeny. The Aayog, which comes under the Ministry of Fisheries, Animal Husbandry and Dairying, has started a nation-wide campaign to encourage the use of cow dung-based products during festivals.
Kathiria further appealed to

Read More

Recall Widens for Diabetes Drug Metformin

Dovie Salais

Oct. 12, 2020 – The recall of extended-release metformin continues this month as 76 more lots have been flagged for a possible cancer-causing ingredient.

The FDA announced the latest recall, involving Marksans Pharma Limited and Sun Pharmaceutical Industries products, on Oct. 5. It involves the 500mg and 700mg tablets. More than 175 different drug combinations have been recalled since late May.

Consumers can see all the recalled metformin products at this FDA website. The agency says that immediate-release metformin does not appear to have the same contamination problem.

The FDA has been investigating the presence of nitrosamines, known to be a possible carcinogen, in the popular diabetes medications since December, when it was first discovered in drugs in other countries. The agency said this month they still do not know the source of nitrosamines in the medications.

The investigation, and subsequent recalls, follows similar ones for

Read More

New Procedure May Eliminate Need for Insulin with Type 2 Diabetes

Dovie Salais
Share on Pinterest
The outpatient procedure performed well with participants in a clinical trial. It could eliminate the need for insulin for some people with type 2 diabetes. Credit Image: Jayme Burrows/Stocksy
  • A new procedure could help eliminate the need for insulin for some people with type 2 diabetes.
  • The results of a clinical trial involving the new technique were unveiled today at a conference.
  • The outpatient procedure involves inserting a catheter into a part of the intestine to destroy mucosal cells that have changed as a result of diabetes.

More than 34 million people in the United States currently have diabetes. This is more than 10 percent of the U.S. population.

While insulin — the primary way of treating and managing diabetes — has been around for more than a century, skyrocketing insulin prices in the past decade have led to desperate actions from people with diabetes.

Some have

Read More

Kantar Health and CATS Foundation Present Updated GM2 Disease Registry at 2020 NORD Rare Diseases & Orphan Products Breakthrough Summit

Dovie Salais

NEW YORK–(BUSINESS WIRE)–Kantar Health, a leading global healthcare data, analytics and research provider, and the Cure & Action for Tay-Sachs (CATS) Foundation presented the latest version of the GM2 Disease Registry at the 2020 NORD Rare Diseases & Orphan Products Breakthrough Summit, held October 8-9.

The GM2 Disease Registry (GM2DR) was established in 2015 to increase awareness of and support for clinical research on Tay-Sachs and Sandhoff Disease. In the United States a rare disease is defined as a condition that affects fewer than 200,000 people. Tay-Sachs affects 1 in 320,000 people and Sandhoff affects 1 in 300,000 people.

Managed by CATS, GM2DR leverages the Open App system, which includes patient data such as genotype and key disease milestones including seizure activity and feeding intervention.

There are currently 85 TS and 29 SD patients included in the registry, making it a valuable research platform of real-world data that

Read More

With depression, there’s no ‘one size fits all’ approach | Opinion

Dovie Salais

By Thomas P. Murt

Depression is one of the most common mental health disorders in the United States, making it a leading cause of disability for individuals aged 15-44. The illness is classified as “persistent sadness and a loss of interest in activities that you normally enjoy, accompanied by an inability to carry out daily activities for at least two weeks” by the World Health Organization.

As a condition, depression can be caused by a multitude of factors. These causes can include chemical imbalances within the brain and body, genetics, chronic pain, stress, life events and trauma. Individuals living with depression are affected in different ways and in varying degrees. During the COVID-19 pandemic, symptoms of depression may be experienced in an amplified manner due to the constant changes and unknown situations.

There have been increasing incidents of depression, especially during the COVID-19 pandemic. In these unprecedented times, it is

Read More

Could Type 1 Diabetes Begin in Utero?

Dovie Salais

Infants might develop type 1 diabetes in the first 6 months of life and seems to be unrelated to known genetic risk factors; rather, it appears linked to low birth weight, say UK researchers.

They believe the discovery could mean the disease starts in utero.

Others are skeptical, however.

The team studied 166 infants with diabetes diagnosed before 6 months of age and compared them to babies with the more common neonatal diabetes and children diagnosed with type 1 diabetes at older ages.

The combination of high type 1 diabetes genetic risk score (T1D-GRS), presence of islet-specific autoantibodies, and evidence of a rapid loss of insulin secretion all suggest that the infants had type 1 diabetes.

And notably, they all had a lower median birth weight than international reference standards.

“This study proves that type 1 diabetes can present in the first few months of life, and in a tiny

Read More

October Is National Breast Cancer Awareness Month & Metastatic Breast Cancer Is One Of The Diseases Treated At Austin CyberKnife.

Dovie Salais

Posted: Updated:

In honor of Breast Cancer Awareness Month, Dr. Kirsten Warhoe, M.D., board-certified radiation oncologist at Austin CyberKnife shares how metastatic cancer is treated with the CyberKnife® Robotic Radiosurgery System, and how Austin CyberKnife is safely treating patients during COVID-19.

What is metastatic breast cancer?

– Metastatic cancer is cancer that has spread from the part of the body where it started (the primary site) to other parts of the body.  With metastatic breast cancer (also called stage IV), it is cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body.

– Although metastatic breast cancer has spread to another part of the body, it’s still breast cancer and treated as breast cancer.

– Breast cancer can come back in another part of the body months or

Read More

From Back Pain to Coughing, Life with Long-Haul COVID-19

Dovie Salais
Share on Pinterest
Some people have persistent symptoms of COVID-19 long after the worst of the infection has passed. Credit Image: Daniel Lozano Gonzale/Getty Images
  • More than 9 months since the COVID-19 pandemic started in the United States, some people still have symptoms long after they’ve “recovered.”
  • Experts are learning more about these “long-haul” COVID-19 cases.
  • Symptoms are wide-ranging, and there’s little experts can do to treat them.

In April, Dr. Scott Krakower, a child psychiatrist at Zucker Hillside Hospital in Glen Oaks, New York, was diagnosed with COVID-19.

It took 4 months for him to begin to feel like his normal self again, and he’s still coping with lingering symptoms.

“I was coughing until almost 3 weeks ago or so — and honestly, I started coughing again yesterday, so I don’t know,” Krakower told Healthline.

“I still cough, but it’s few and far between now,” he continued.

Krakower is

Read More

I Struggle with Diabetes. Don’t Call Me ‘Non-Compliant’

Dovie Salais

When Ally Hughes arrived for a routine eye exam, she had no idea the optometrist would also be judging her entire diabetes management effort.

“I was just getting an update for my glasses, and the tech was asking for health information,” recalls Hughes, a PhD health researcher and advocate in Boston who’s lived with type 1 diabetes (T1D) for 24 years since age 7. Over the years, she had no history or evidence of diabetic eye disease.

“After the exam, the tech sat down and immediately wrote ‘type 1 non-compliant’ on my chart, right in front of me, for billing coding.”

Hughes was especially alarmed and offended because this healthcare professional didn’t have access to her A1C lab test history or any blood sugar data, at all.

“She met me at face value and labeled me as ‘non-compliant,’” adds a frustrated Hughes. “I asked her why she was

Read More